Skip to main content

DI‐II.

By

DI‐II.

I found four studies to assess a range of measurement properties of the BDI‐II in general population adults, without comorbid conditions. There was weak evidence in support of internal consistency—many studies did not calculate Cronbach's alpha for each subscale separately. However, all studies showed support for the internal consistency of the BDI‐II total score with acceptable alphas above (.7). There was weak evidence in support of test‐retest reliability with one fair study (as it was unclear how missing items were handled), with a high alpha (.89). There was strong evidence for content validity in one methodologically excellent study of the BDI‐II in a non-English speaking Kenyan sample. There was moderate evidence in support of structural validity from the two studies. Both studies showed fair evidence for a single factor solution. Evidence for hypothesis testing was moderate—the BDI‐II showed acceptable correlations with other depression measures (r > .57). There was weak evidence for cross-cultural validity as there were weaknesses in the quality of the translations (only one forward/backwards translation), or failure to pretest the items in a sample for interpretability and cultural relevance. There was moderate evidence for criterion validity. The BDI‐II showed adequate sensitivity (>.7) and specificity (>.8) in determining Major Depressive Episodes with clinician ratings used as the criterion.

 

PHQ‐9. Six studies were found that explored a range of measurement properties of the PHQ‐9 in general population adults. There was moderate evidence in support of internal consistency with adequate Cronbach's alphas (>.7) for the unidimensional measure (confirmed using IRT methods and factor analytic methods). There was moderate evidence in support of test‐retest reliability with correlations >.7. There was moderate evidence for structural validity showing consistent evidence for a one-factor solution (using factor analysis). There was moderate evidence for hypothesis testing; the PHQ‐9 correlated strongly with other measures of similar constructs (e.g., the BDI), and support was found for consistent factor structure across time points and subgroups. There was moderate evidence for criterion validity, with acceptable sensitivity and specificity (>.79) in detecting clinical diagnosis of depressive disorder.

Labels:

Comments

Post a Comment

Your Thoughts?

Popular posts from this blog

ICD-11 Criteria for Single Episode Depressive Disorder (Depressive Episode) (6A70)

By
ICD-11 Criteria for Single Episode Depressive Disorder (Depressive Episode) (6A70) Single episode depressive disorder is characterised by the presence or history of one depressive episode when there is no history of prior depressive episodes. A depressive episode is characterised by a period of depressed mood or diminished interest in activities occurring most of the day, nearly every day during a period lasting at least two weeks accompanied by other symptoms such as difficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor agitation or retardation, and reduced energy or fatigue. There have never been any prior manic, hypomanic, or mixed episodes, which would indicate the presence of a bipolar disorder. Exclusions:              Recurrent depressive disorder (6A71) Adjustment disorder (6B43) Bipolar...
Post a Comment
Read more

ICD-11 Criteria for Depression (Recurrent Depressive Disorder) 6A71

By
ICD-11 Criteria for Depression (Recurrent Depressive Disorder) 6A71 Recurrent depressive disorder is characterised by a history or at least two depressive episodes separated by at least several months without significant mood disturbance. A depressive episode is characterised by a period of depressed mood or diminished interest in activities occurring most of the day, nearly every day during a period lasting at least two weeks accompanied by other symptoms such as difficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor agitation or retardation, and reduced energy or fatigue. There have never been any prior manic, hypomanic, or mixed episodes, which would indicate the presence of a Bipolar disorder. Inclusions:                Seasonal depressive disorder Exclusions:    ...
Post a Comment
Read more

ICD-11 Criteria for Bipolar Type-1 Disorder

By
ICD-11 Criteria for Bipolar Type-1 Disorder    6A60     Bipolar type I disorder is an episodic mood disorder defined by the occurrence of one or more manic or mixed episodes. A manic episode is an extreme mood state lasting at least one week unless shortened by a treatment intervention characterised by euphoria, irritability, or expansiveness, and by increased activity or a subjective experience of increased energy, accompanied by other characteristic symptoms such as rapid or pressured speech, flight of ideas, increased self-esteem or grandiosity, decreased need for sleep, distractibility, impulsive or reckless behaviour, and rapid changes among different mood states (i.e., mood lability). A mixed episode is characterised by the presence of several prominent manic and several prominent depressive symptoms consistent with those observed in manic episodes and depressive episodes, which either occur simultaneously or alternate very rapidly (from day to day or with...
Post a Comment
Read more